mibefradil has been researched along with Hydronephrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, K; Homma, K; Kanda, T; Ozawa, Y; Saruta, T; Takamatsu, I; Tatematsu, S; Wakino, S | 1 |
| Hayashi, K; Homma, K; Kanda, T; Kumagai, H; Okubo, K; Ozawa, Y; Saruta, T; Takamatsu, I; Tatematsu, S; Wakino, S | 1 |
| Fujiwara, K; Hayashi, K; Nagahama, T; Ozawa, Y; Saruta, T | 1 |
3 other study(ies) available for mibefradil and Hydronephrosis
| Article | Year |
|---|---|
Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
Topics: Analysis of Variance; Angiotensin II; Animals; Calcium Channel Blockers; Hydronephrosis; Male; Mibefradil; Rats; Rats, Inbred WKY; Renal Circulation; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats--studies in the isolated perfused hydronephrotic kidney.
Topics: Angiotensin II; Animals; Arterioles; Calcium; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydronephrosis; Hypertension; Kidney; Male; Mibefradil; Microcirculation; Nifedipine; Perfusion; Protein Kinase C; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Staurosporine; Thapsigargin; Vasodilator Agents | 2005 |
Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
Topics: Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Hydronephrosis; In Vitro Techniques; Kidney; Male; Mibefradil; Nifedipine; Norepinephrine; Phentolamine; Rats; Rats, Wistar; Renal Artery; Renal Circulation; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2001 |